[Federal Register Volume 68, Number 209 (Wednesday, October 29, 2003)]
[Notices]
[Page 61699]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-27243]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By notice dated June 6, 2003, and published in the Federal Register 
on June 19, 2003, (68 FR 36844), Eli-Elsohly Laboratories, Inc., 
Mahmoud A. Elsohly, Ph.D., 5 Industrial Park Drive, Oxford, Mississippi 
38655, made application by renewal to the Drug Enforcement 
Administration to be registered as a bulk manufacturer of the basic 
classes of Schedules I and II controlled substances listed below:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Tetrahydrocannabinols (7370)...............  I
Dihydromorphine (9145).....................  I
Codeine (9050).............................  II
Amphetamine (1100).........................  II
Methamphetamine (1105).....................  II
Cocaine (9041).............................  II
Codeine (9050).............................  II
 Dihydrocodeine (9120).....................  II
 Oxycodone (9143)..........................  II
 Hydromorphone (9150)......................  II
 Benzoylecognine (9180)....................  II
 Hydrocodone (9193)........................  II
 Morphine (9300)...........................  II
------------------------------------------------------------------------

    The firm plans to manufacture non-deuterated controlled substances 
for use as analytical standards and deuterated controlled substances 
for use as internal standards.
    No comments or objections have been received. DEA has considered 
the factors in title 21, United States Code, section 823(a) and 
determined that the registration of Eli-Elsohly Laboratories, Inc. to 
manufacture the listed controlled substances is consistent with the 
public interest at this time. DEA has investigated Eli-Elsohly 
Laboratories, Inc. to ensure that the company's registration is 
consistent with the public interest. This investigation has included 
inspection and testing of the company's physical security systems, 
verification of the company's compliance with state and local laws, and 
a review of the company's background and history. Therefore, pursuant 
to 21 U.S.C. 823 and 28 CFR 0.100 and 0.104, the Deputy Assistant 
Administrator, Office of Diversion Control, hereby orders that the 
application submitted by the above firm for registration as a bulk 
manufacturer of the basic classes of controlled substances listed is 
granted.

    Dated: October 15, 2003.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 03-27243 Filed 10-28-03; 8:45 am]
BILLING CODE 4410-09-M